Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Soloway

Showing results (231-240 of 252) with videos related to

Pageof 26
Sort By:
The Journal of Urology|December 3, 2013
Differential expression of SDF-1 isoforms in bladder cancerMiguel Gosalbez, Marie C Hupe, Soum D Lokeshwar, et al.
The Journal of Urology|January 17, 2012
Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasisJeffrey C Gahan, Miguel Gosalbez, Travis Yates, et al.
European Urology|January 15, 2013
Screening for bladder cancer: rationale, limitations, whom to target, and perspectivesStéphane Larré, James W F Catto, Michael S Cookson, et al.
European Urology|October 24, 2012
A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimensDonna E Hansel, Mahul B Amin, Eva Comperat, et al.
European Urology|April 7, 2009
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancerMario W Kramer, Roozbeh Golshani, Axel S Merseburger, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladderGeorgios Gakis, Jason Efstathiou, Seth P Lerner, et al.
The Journal of Biological Chemistry|August 23, 2008
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoterVinata B Lokeshwar, Pablo Gomez, Mario Kramer, et al.
Cancer|September 6, 2013
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancerMatthew Truong, Jon A Slezak, Chee Paul Lin, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
The Journal of Urology|May 22, 2019
Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGADaley S Morera, Sarrah L Hasanali, Daniel Belew, et al.
Pageof 26

Showing results (231-240 of 252) with videos related to

Sort By:
Pageof 26
The Journal of Urology|December 3, 2013
Differential expression of SDF-1 isoforms in bladder cancerMiguel Gosalbez, Marie C Hupe, Soum D Lokeshwar, et al.
The Journal of Urology|January 17, 2012
Chemokine and chemokine receptor expression in kidney tumors: molecular profiling of histological subtypes and association with metastasisJeffrey C Gahan, Miguel Gosalbez, Travis Yates, et al.
European Urology|January 15, 2013
Screening for bladder cancer: rationale, limitations, whom to target, and perspectivesStéphane Larré, James W F Catto, Michael S Cookson, et al.
European Urology|October 24, 2012
A contemporary update on pathology standards for bladder cancer: transurethral resection and radical cystectomy specimensDonna E Hansel, Mahul B Amin, Eva Comperat, et al.
European Urology|April 7, 2009
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancerMario W Kramer, Roozbeh Golshani, Axel S Merseburger, et al.
European Urology|August 25, 2012
ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladderGeorgios Gakis, Jason Efstathiou, Seth P Lerner, et al.
The Journal of Biological Chemistry|August 23, 2008
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoterVinata B Lokeshwar, Pablo Gomez, Mario Kramer, et al.
Cancer|September 6, 2013
Development and multi-institutional validation of an upgrading risk tool for Gleason 6 prostate cancerMatthew Truong, Jon A Slezak, Chee Paul Lin, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
The Journal of Urology|May 22, 2019
Clinical Parameters Outperform Molecular Subtypes for Predicting Outcome in Bladder Cancer: Results from Multiple Cohorts, Including TCGADaley S Morera, Sarrah L Hasanali, Daniel Belew, et al.
Pageof 26